NIM
AKRO

NEOS Investment Management’s Akero Therapeutics AKRO Stock Holding History

NEOS Investment Management’s Portfolio AKRO Stock Details AKRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-6,632
Closed -$315K – 651
2025
Q3 		$315K Sell
6,632
-3,607
-35% -$175K ﹤0.01% 607
2025
Q2 		$546K Sell
10,239
-1,539
-13% -$69.9K 0.01% 533
2025
Q1 		$477K Sell
11,778
-20,372
-63% -$863K 0.01% 517
2024
Q4 		$894K Sell
32,150
-10,929
-25% -$331K 0.02% 425
2024
Q3 		$1.24M Buy
43,079
+3,325
+8% +$86.7K 0.04% 334
2024
Q2 		$933K Buy
39,754
+8,225
+26% +$176K 0.04% 338
2024
Q1 		$796K Buy
+31,529
New +$757K 0.05% 303

Other funds holding AKRO

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

NEOS Investment Management's AKRO Position: Q4 2025 in Review

NEOS Investment Management sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 6,632 shares — an estimated $315K sold.

NEOS Investment Management first reported a position in AKRO in Q1 2024 and held it in 7 quarters. The position peaked at $1.24M in Q3 2024. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

  • NEOS Investment Management reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
  • NEOS Investment Management sold 6,632 Akero Therapeutics shares in Q4 2025, an estimated $315K.
  • NEOS Investment Management first reported a position in Akero Therapeutics in Q1 2024 and held it in 7 quarters.
  • NEOS Investment Management's Akero Therapeutics position peaked at $1.24M in Q3 2024.
  • 2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on NEOS Investment Management's 13F filing for Q4 2025, filed 17 Feb 2026.